Pharmaceutical Business Intelligence

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Pentobarbital - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for pentobarbital?

Pentobarbital is the generic ingredient in four branded drugs marketed by Oak Pharms, Purepac Pharm, Mylan Institutional, Lannett, Whiteworth Town Plsn, Nexgen Pharma Inc, Wyeth Ayerst, Parke Davis, Everylife, Perrigo, Ivax Sub Teva Pharms, Valeant Pharm Intl, Elkins Sinn, Halsey, Vitarine, Anabolic, and Watson Labs, and is included in twenty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentobarbital.

Summary for Generic Name: pentobarbital

Drug Master File Entries: see list2
Bulk Api Vendors: see list23
Clinical Trials: see list6
Patent Applications: see list14,594
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pentobarbital at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
pentobarbital sodium
CAPSULE;ORAL084677-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Oak Pharms
pentobarbital sodium
SUPPOSITORY;RECTAL083247-003Jan 25, 1982DISCNNoNo► Subscribe► Subscribe
Oak Pharms
pentobarbital sodium
SUPPOSITORY;RECTAL083247-002Jan 25, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
pentobarbital sodium
CAPSULE;ORAL085791-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Purepac Pharm
pentobarbital sodium
CAPSULE;ORAL083301-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.